Dynamic reorganization of the AC16 cardiomyocyte transcriptome in response to TNFα signaling revealed by integrated genomic analyses

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Luo, Xin ^a,b   Chae, Minho ^a,b   Krishnakumar, Raga ^c,e   Danko, Charles G ^c,d   Kraus, W L ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d Plant Breeding and Genetics Section in the School of Integrative Plant Science   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMANITIN; DNA DIRECTED RNA POLYMERASE; DNA DIRECTED RNA POLYMERASE III; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; RNA POLYMERASE II; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BINDING SITE; CARDIOVASCULAR DISEASE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REPRESSION; GENE EXPRESSION; GENETIC CODE; GENETIC ORGANIZATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; GLOBAL NUCLEAR RUN ON SEQUENCING; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INFLAMMATION; INTRACELLULAR SIGNALING; SEQUENCE DATABASE; SIGNAL TRANSDUCTION; STEADY STATE; TRANSCRIPTION ELONGATION; TRANSCRIPTOMICS; UPREGULATION;

ADULT; ALPHA-AMANITIN; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MYOCYTES, CARDIAC; NF-KAPPA B; RNA POLYMERASE I; RNA POLYMERASE II; RNA POLYMERASE III; RNA, MESSENGER; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84895556767     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-155     Document Type: Article

References (67)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-e245. 10.1161/CIR.0b013e31828124ad, 23239837.
2. Koenig W. Inflammation and coronary heart disease: an overview. Cardiol Rev 2001, 9:31-35. 10.1097/00045415-200101000-00007, 11174913.
3. Taubes G. Cardiovascular disease. Does inflammation cut to the heart of the matter?. Science 2002, 296:242-245. 10.1126/science.296.5566.242, 11951014.
4. Biasillo G, Leo M, Della Bona R, Biasucci LM. Inflammatory biomarkers and coronary heart disease: from bench to bedside and back. Intern Emerg Med 2010, 5:225-233. 10.1007/s11739-010-0361-1, 20182820.
5. Coggins M, Rosenzweig A. The fire within: cardiac inflammatory signaling in health and disease. Circ Res 2012, 110:116-125. 10.1161/CIRCRESAHA.111.243196, 22223209.
6. Yndestad A, Damas JK, Oie E, Ueland T, Gullestad L, Aukrust P. Role of inflammation in the progression of heart failure. Curr Cardiol Rep 2007, 9:236-241. 10.1007/BF02938356, 17470337.
7. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007, 13:952-961. 10.1038/nm1613, 17660828.
8. van Nieuwenhoven FA, Turner NA. The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vascul Pharmacol 2013, 58:182-188. 10.1016/j.vph.2012.07.003, 22885638.
9. Maier HJ, Schips TG, Wietelmann A, Kruger M, Brunner C, Sauter M, Klingel K, Bottger T, Braun T, Wirth T. Cardiomyocyte-specific IkappaB kinase (IKK)/NF-kappaB activation induces reversible inflammatory cardiomyopathy and heart failure. Proc Natl Acad Sci USA 2012, 109:11794-11799. 10.1073/pnas.1116584109, 3406816, 22753500.
10. Wang HY, Liu XY, Han G, Wang ZY, Li XX, Jiang ZM, Jiang CM. LPS induces cardiomyocyte injury through calcium-sensing receptor. Mol Cell Biochem 2013, 379:153-159. 10.1007/s11010-013-1637-3, 3666124, 23564188.
11. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, Mahajan A, Wang Q, Sen S. Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol 2008, 375:637-649. 10.1016/j.jmb.2007.10.006, 2277468, 18037434.
12. Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB. Circ Res 2011, 108:1122-1132. 10.1161/CIRCRESAHA.110.226928, 21527742.
13. Hah N, Danko CG, Core L, Waterfall JJ, Siepel A, Lis JT, Kraus WL. A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 2011, 145:622-634. 10.1016/j.cell.2011.03.042, 3099127, 21549415.
14. Hah N, Kraus WL. Hormone-regulated transcriptomes: Lessons learned from estrogen signaling pathways in breast cancer cells. Mol Cell Endocrinol 2013, 382:652-664.
15. Han M, Toli J, Abdellatif M. MicroRNAs in the cardiovascular system. Curr Opin Cardiol 2011, 26:181-189. 10.1097/HCO.0b013e328345983d, 21464712.
16. Scheuermann JC, Boyer LA. Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. EMBO J 2013, 32:1805-1816. 10.1038/emboj.2013.134, 23756463.
17. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009, 27:693-733. 10.1146/annurev.immunol.021908.132641, 19302050.
18. Core LJ, Waterfall JJ, Lis JT. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 2008, 322:1845-1848. 10.1126/science.1162228, 2833333, 19056941.
19. Danko CG, Hah N, Luo X, Martins AL, Core L, Lis JT, Siepel A, Kraus WL. Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells. Mol Cell 2013, 50:212-222. 10.1016/j.molcel.2013.02.015, 23523369.
20. Hah N, Murakami S, Nagari A, Danko C, Kraus WL. Enhancer transcripts mark active estrogen receptor binding sites. Genome Res 2013, 23:1201-1223.
21. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26:139-140. 10.1093/bioinformatics/btp616, 2796818, 19910308.
22. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, Spiller DG, et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 2004, 306:704-708. 10.1126/science.1099962, 15499023.
23. Russell J, Zomerdijk JC. RNA-polymerase-I-directed rDNA transcription, life and works. Trends Biochem Sci 2005, 30:87-96. 10.1016/j.tibs.2004.12.008, 3858833, 15691654.
24. Paule MR, White RJ. Survey and summary: transcription by RNA polymerases I and III. Nucleic Acids Res 2000, 28:1283-1298. 10.1093/nar/28.6.1283, 111039, 10684922.
25. Barski A, Chepelev I, Liko D, Cuddapah S, Fleming AB, Birch J, Cui K, White RJ, Zhao K. Pol II and its associated epigenetic marks are present at Pol III-transcribed noncoding RNA genes. Nat Struct Mol Biol 2010, 17:629-634. 10.1038/nsmb.1806, 2917008, 20418881.
26. Moqtaderi Z, Wang J, Raha D, White RJ, Snyder M, Weng Z, Struhl K. Genomic binding profiles of functionally distinct RNA polymerase III transcription complexes in human cells. Nat Struct Mol Biol 2010, 17:635-640. 10.1038/nsmb.1794, 3350333, 20418883.
27. Oler AJ, Alla RK, Roberts DN, Wong A, Hollenhorst PC, Chandler KJ, Cassiday PA, Nelson CA, Hagedorn CH, Graves BJ, Cairns BR. Human RNA polymerase III transcriptomes and relationships to Pol II promoter chromatin and enhancer-binding factors. Nat Struct Mol Biol 2010, 17:620-628. 10.1038/nsmb.1801, 2945309, 20418882.
28. Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, Kuersten S, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010, 465:182-187. 10.1038/nature09033, 3020079, 20393465.
29. Lam MT, Cho H, Lesch HP, Gosselin D, Heinz S, Tanaka-Oishi Y, Benner C, Kaikkonen MU, Kim AS, Kosaka M, et al. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 2013, 498:511-515. 10.1038/nature12209, 3839578, 23728303.
30. Li W, Notani D, Ma Q, Tanasa B, Nunez E, Chen AY, Merkurjev D, Zhang J, Ohgi K, Song X, et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 2013, 498:516-520. 10.1038/nature12210, 3718886, 23728302.
31. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010, 143:46-58. 10.1016/j.cell.2010.09.001, 20887892.
32. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, Clementi L, Ren J, Li WW, Noble WS. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res 2009, 37:W202-208. 10.1093/nar/gkp335, 2703892, 19458158.
33. Bailey TL, Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 1994, 2:28-36.
34. Parks DH, Beiko RG. Identifying biologically relevant differences between metagenomic communities. Bioinformatics 2010, 26:715-721. 10.1093/bioinformatics/btq041, 20130030.
35. Stein B, Baldwin AS, Ballard DW, Greene WC, Angel P, Herrlich P. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 1993, 12:3879-3891. 413671, 8404856.
36. Frantz S, Fraccarollo D, Wagner H, Behr TM, Jung P, Angermann CE, Ertl G, Bauersachs J. Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. Cardiovasc Res 2003, 57:749-756. 10.1016/S0008-6363(02)00723-X, 12618236.
37. Dellow KA, Bhavsar PK, Brand NJ, Barton PJ. Identification of novel, cardiac-restricted transcription factors binding to a CACC-box within the human cardiac troponin I promoter. Cardiovasc Res 2001, 50:24-33. 10.1016/S0008-6363(01)00204-8, 11282075.
38. Flesch M. On the trail of cardiac specific transcription factors. Cardiovasc Res 2001, 50:3-6. 10.1016/S0008-6363(01)00218-8, 11282072.
39. Danko CG, Pertsov AM. Identification of gene co-regulatory modules and associated cis-elements involved in degenerative heart disease. BMC Med Genomics 2009, 2:31. 10.1186/1755-8794-2-31, 2700136, 19476647.
40. Huang XR, Chung AC, Yang F, Yue W, Deng C, Lau CP, Tse HF, Lan HY. Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension 2010, 55:1165-1171. 10.1161/HYPERTENSIONAHA.109.147611, 20231525.
41. Halbig KM, Lekven AC, Kunkel GR. The transcriptional activator ZNF143 is essential for normal development in zebrafish. BMC Mol Biol 2012, 13:3. 10.1186/1471-2199-13-3, 3282657, 22268977.
42. Jacques AM, Briceno N, Messer AE, Gallon CE, Jalilzadeh S, Garcia E, Kikonda-Kanda G, Goddard J, Harding SE, Watkins H, et al. The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy. Cardiovasc Res 2008, 79:481-491. 10.1093/cvr/cvn094, 2492731, 18411228.
43. Vasquez C, Benamer N, Morley GE. The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts. J Cardiovasc Pharmacol 2011, 57:380-388. 10.1097/FJC.0b013e31820cda19, 3077441, 21242811.
44. Kienesberger PC, Pulinilkunnil T, Nagendran J, Dyck JR. Myocardial triacylglycerol metabolism. J Mol Cell Cardiol 2013, 55:101-110.
45. Guertl B, Noehammer C, Hoefler G. Metabolic cardiomyopathies. Int J Exp Pathol 2000, 81:349-372. 2517748, 11298185.
46. Lemieux H, Semsroth S, Antretter H, Hofer D, Gnaiger E. Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. Int J Biochem Cell Biol 2011, 43:1729-1738. 10.1016/j.biocel.2011.08.008, 21871578.
47. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010, 28:495-501. 10.1038/nbt.1630, 20436461.
48. Li H, Tang QZ, Liu C, Moon M, Chen M, Yan L, Bian ZY, Zhang Y, Wang AB, Nghiem MP, Liu PP. Cellular FLICE-inhibitory protein protects against cardiac remodeling induced by angiotensin II in mice. Hypertension 2010, 56:1109-1117. 10.1161/HYPERTENSIONAHA.110.157412, 20975036.
49. Cheng Y, Zhang C. MicroRNA-21 in cardiovascular disease. J Cardiovasc Transl Res 2010, 3:251-255. 10.1007/s12265-010-9169-7, 3611957, 20560046.
50. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984. 10.1038/nature07511, 19043405.
51. Thum T, Catalucci D, Bauersachs J. MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res 2008, 79:562-570. 10.1093/cvr/cvn137, 18511432.
52. Davidson MM, Nesti C, Palenzuela L, Walker WF, Hernandez E, Protas L, Hirano M, Isaac ND. Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol 2005, 39:133-147. 10.1016/j.yjmcc.2005.03.003, 15913645.
53. Kininis M, Chen BS, Diehl AG, Isaacs GD, Zhang T, Siepel AC, Clark AG, Kraus WL. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol Cell Biol 2007, 27:5090-5104. 10.1128/MCB.00083-07, 1951957, 17515612.
54. Krishnakumar R, Gamble MJ, Frizzell KM, Berrocal JG, Kininis M, Kraus WL. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 2008, 319:819-821. 10.1126/science.1149250, 18258916.
55. Johnson DS, Mortazavi A, Myers RM, Wold B. Genome-wide mapping of in vivo protein-DNA interactions. Science 2007, 316:1497-1502. 10.1126/science.1141319, 17540862.
56. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T, Euskirchen G, Bernier B, Varhol R, Delaney A, et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 2007, 4:651-657. 10.1038/nmeth1068, 17558387.
57. May D, Blow MJ, Kaplan T, McCulley DJ, Jensen BC, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, et al. Large-scale discovery of enhancers from human heart tissue. Nat Genet 2012, 44:89-93.
58. Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, Kellis M, Marra MA, Beaudet AL, Ecker JR, et al. The NIH roadmap epigenomics mapping consortium. Nat Biotechnol 2010, 28:1045-1048. 10.1038/nbt1010-1045, 3607281, 20944595.
59. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. 10.1038/nature11247, 3439153, 22955616.
60. Wang H, Maurano MT, Qu H, Varley KE, Gertz J, Pauli F, Lee K, Canfield T, Weaver M, Sandstrom R, et al. Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res 2012, 22:1680-1688. 10.1101/gr.136101.111, 3431485, 22955980.
61. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009, 10:R25. 10.1186/gb-2009-10-3-r25, 2690996, 19261174.
62. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010, 26:841-842. 10.1093/bioinformatics/btq033, 2832824, 20110278.
63. Li R, Yu C, Li Y, Lam TW, Yiu SM, Kristiansen K, Wang J. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 2009, 25:1966-1967. 10.1093/bioinformatics/btp336, 19497933.
64. Rhead B, Karolchik D, Kuhn RM, Hinrichs AS, Zweig AS, Fujita PA, Diekhans M, Smith KE, Rosenbloom KR, Raney BJ, et al. The UCSC genome browser database: update 2010. Nucleic Acids Res 2010, 38:D613-619. 10.1093/nar/gkp939, 2808870, 19906737.
65. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-144. 10.1093/nar/gkj112, 1347474, 16381832.
66. Development Core Team R. R: A Language and Environment for Statistical Computing 2006, Vienna, Austria: R Foundation for Statistical Computing.
67. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.